Mice that are homozygous for the PLN-R14del pathogenic variant (PLN-R14 Δ/Δ) develop cardiomyopathy, PLN protein aggregation and HF in an accelerated manner with early mortality within 2 months, providing an opportunity to screen novel therapies [15,16]. Here, PLN is linked to cardiomyopathy.